The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals with respect to news article appearing in Business Standard dated June 6, 2015 titled ‘CCI slaps Rs 64 crore fine on GlaxoSmithKline, Sanofi’.
The above information is a part of company’s filings submitted to BSE.